Which of the following nucleoside reverse transcriptase inhibitors has the best penetration into CSF? a. Zidovudine b. Didanosine c. Lamivudine d. Stavudine e. Abacavir

Short Answer

Expert verified
Answer: a. Zidovudine

Step by step solution

01

List the given NRTIs

Here are the NRTIs from the exercise: a. Zidovudine b. Didanosine c. Lamivudine d. Stavudine e. Abacavir
02

Compare CSF penetration

To determine which NRTI has the best CSF penetration, we need to compare their respective CSF-to-plasma AUC (Area Under the Curve) ratio. This ratio determines how well a drug penetrates the CSF. The higher the ratio, the better the penetration. Here are the CSF-to-plasma AUC ratios for each NRTI: a. Zidovudine: 0.6-0.7 b. Didanosine: 0.2 c. Lamivudine: 0.12 d. Stavudine: 0.29 e. Abacavir: 0.3
03

Choose the NRTI with the highest CSF-to-plasma ratio

Based on the listed CSF-to-plasma AUC ratios, Zidovudine has the highest ratio (0.6-0.7), indicating superior CSF penetration compared to the other NRTIs.
04

Answer:

The nucleoside reverse transcriptase inhibitor with the best penetration into CSF is: a. Zidovudine

Unlock Step-by-Step Solutions & Ace Your Exams!

  • Full Textbook Solutions

    Get detailed explanations and key concepts

  • Unlimited Al creation

    Al flashcards, explanations, exams and more...

  • Ads-free access

    To over 500 millions flashcards

  • Money-back guarantee

    We refund you if you fail your exam.

Over 30 million students worldwide already upgrade their learning with Vaia!

One App. One Place for Learning.

All the tools & learning materials you need for study success - in one app.

Get started for free

Most popular questions from this chapter

In a busy clinical practice setting, the simplest neuropsychological test to diagnose HIV dementia is? a. Standard Mini-Mental Status test b. HIV-dementia scale c. Memorial Sloan Kettering Scale d. Halstead-Reitan Neuropsychological Battery e. San Diego HIV Neurobehavioral Research Center

Recent guidelines for starting anti-retroviral therapy recommend that patients with advanced disease, as manifested by the development of an AIDS-defining illness including HAD, or presence of severe symptoms such as unexplained fever, persistent diarrhea, or unexplained weight loss, should be started on ART if their \(\mathrm{CD}^{*} \mathrm{~T}\) cell count is \(<\mathbf{1 0 0}\). True/False

A patient with HIV-associated dementia was started on antiretroviral therapy two weeks ago. He complains of dizziness, insomnia, and vivid dreams. This reaction is most likely related to the use of: a. Zidovudine b. Tenofovir c. Lamivudine d. Efavirenz e. Nevirapine

What is not correct in regards to a diagnosis of HIVassociated dementia? a. HAD is a diagnosis of exclusion b. HIV does elicit an inflammatory response. This can be detected by mild lymphocytic pleocytosis, elevation of total protein, increase of total IgG, and/or the presence of oligoclonal bands c. HAD is always associated with a concurrent diagnosis of progressive multifocal leukoencephalopathy d. HAD almost always is associated with \(\mathrm{CD}^{+} \mathrm{T}\) cell counts of less than 600 e. The clinical manifestations of HAD include behavioral, cognitive, and/or motor abnormalities

Currently there are six classes of antiretroviral agents available in the United States for clinical use: \- Nucleoside analogue reverse transcriptase inhibitors \- Nonnucleoside analogue reverse transcriptase inhibitors \- Protease inhibitors \- Entry inhibitors \- Tat inhibitors \- Nef inhibitors True/False

See all solutions

Recommended explanations on Biology Textbooks

View all explanations

What do you think about this solution?

We value your feedback to improve our textbook solutions.

Study anywhere. Anytime. Across all devices.

Sign-up for free